Company: PMVP
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000950170-25-104588
Chunk: 0

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 1
Chunk 0
---
PMV Pharmaceuticals, Inc.

Condensed Consolidated Balance Sheets

(unaudited)

(in thousands, except share and per share amounts)

     June 30,2025 (unaudited)

     December 31,2024

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     44,127

     $
     40,876

     Marketable securities, current

     98,147

     128,578

     Prepaid expenses and other current assets

     3,037

     6,204

     Total current assets

     145,311

     175,658

     Property and equipment, net

     287

     409

     Marketable securities, noncurrent

     6,032

     13,843

     Right-of-use assets

     977

     1,143

     Other assets

     248

     235

     Total assets
      
     $
     152,855

     $
     191,288

     Liabilities and Stockholders’ Equity

     Current liabilities:

     Accounts payable
      
     $
     2,598

     $
     6,579

     Accrued expenses

     8,632

     7,439

     Operating lease liabilities, current

     377

     352

     Total current liabilities

     11,607

     14,370

     Operating lease liabilities, noncurrent

     643

     838

     Total liabilities

     12,250

     15,208

     Stockholders’ equity:

     Preferred stock, $0.00001 par value, 5,000,000 shares authorized at June 30, 2025 and December 31, 2024.  No shares issued or outstanding at June 30, 2025 and December 31, 2024.

     —

     —

     Common stock, $0.00001 par value, 1,000,000,000 shares authorized; 52,993,238 and 51,935,134 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively.

     —

     —

     Additional paid-in capital

     547,942

     544,653

     Accumulated deficit

     (407,358
     )

     (368,712